LensGen Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$5.9M
- Investors
-
5
LensGen General Information
Description
Developer of an ophthalmic medical device designed to treat cataracts and presbyopia. The company's device detects eyesight problems by mimicking the eye's natural accommodation process to change shape and adjust focus, enabling patients with cataracts and presbyopia to permanently restore clear and continuous vision at all distances.
Contact Information
Website
www.lensgen.comCorporate Office
- 15310 Barranca Parkway
- Suite 200
- Irvine, CA 92618
- United States
Corporate Office
- 15310 Barranca Parkway
- Suite 200
- Irvine, CA 92618
- United States
LensGen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 02-Mar-2023 | $5.9M | Completed | Generating Revenue | ||
| 8. Later Stage VC (Series B) | 01-Jan-2022 | Completed | Clinical Trials - Phase 1 | |||
| 7. Secondary Transaction - Private | 01-Sep-2021 | Completed | Clinical Trials - Phase 1 | |||
| 6. Later Stage VC | 20-Aug-2020 | Completed | Clinical Trials - Phase 1 | |||
| 5. Later Stage VC (Series A2) | 01-May-2017 | Completed | Clinical Trials - Phase 1 | |||
| 4. Later Stage VC (Series A1) | 01-Sep-2016 | Completed | Clinical Trials - Phase 1 | |||
| 3. Early Stage VC | 16-Nov-2014 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Apr-2014 | $4.5M | Completed | Startup | ||
| 1. Early Stage VC | 10-Sep-2013 | $4.5M | $4.5M | Completed | Startup |
LensGen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Seed | 2,526,726 | $0.000100 | 8% | $0.95 | $0.95 | 1x | $0.95 | 4.83% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
LensGen Comparisons
Industry
Financing
Details
LensGen Competitors (2)
One of LensGen’s 2 competitors is Johnson & Johnson Vision Care, a Corporate Backed or Acquired company based in Jacksonville, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Johnson & Johnson Vision Care | Corporate Backed or Acquired | Jacksonville, FL | ||||
| Alcon | Corporate Backed or Acquired | Geneva, Switzerland |
LensGen Patents
LensGen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020398888-A1 | Fluid lens component for intraocular lens and methods of preparing the same | Inactive | 11-Dec-2019 | ||
| EP-4072472-A1 | Fluid lens component for intraocular lens and methods of preparing the same | Inactive | 11-Dec-2019 | ||
| EP-4072472-A4 | Fluid lens component for intraocular lens and methods of preparing the same | Inactive | 11-Dec-2019 | ||
| US-20230044397-A1 | Fluid lens component for intraocular lens and methods of preparing the same | Pending | 11-Dec-2019 | ||
| WO-2021119174-A1 | Fluid lens component for intraocular lens and methods of preparing the same | Inactive | 11-Dec-2019 | A61F2/1635 |
LensGen Signals
LensGen Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Auctus Global Capital | Venture Capital | Minority | ||
| Hoya | Corporation | Minority | ||
| Relativity Healthcare Partners | Venture Capital | Minority | ||
| ExSight Ventures | Venture Capital | Minority | ||
| MedTech Innovator | Accelerator/Incubator | Minority |
LensGen FAQs
-
When was LensGen founded?
LensGen was founded in 2011.
-
Where is LensGen headquartered?
LensGen is headquartered in Irvine, CA.
-
What is the size of LensGen?
LensGen has 11 total employees.
-
What industry is LensGen in?
LensGen’s primary industry is Therapeutic Devices.
-
Is LensGen a private or public company?
LensGen is a Private company.
-
What is LensGen’s current revenue?
The current revenue for LensGen is .
-
How much funding has LensGen raised over time?
LensGen has raised $90.8M.
-
Who are LensGen’s investors?
Auctus Global Capital, Hoya, Relativity Healthcare Partners, ExSight Ventures, and MedTech Innovator have invested in LensGen.
-
Who are LensGen’s competitors?
Johnson & Johnson Vision Care and Alcon are competitors of LensGen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process